PET scan can non-invasively measure early assessment of treatment for common type of breast ancer

May 26, 2009

By Flinn Foundation

[Source: ScienceDaily] –  Non-invasive imaging can measure how well patients with the most common form of breast cancer – estrogen receptor positive type – respond to standard aromatase inhibitor therapy after only two weeks and shows similar findings that more invasive needle sampling identifies, according to a poster presentation to be presented at the ASCO annual meeting the first week in June.

For more information click here.